439. Atrial Fibrillation: Anti-Arrhythmic Drugs in the Management of Atrial Arrhythmias with Dr. Andrew Epstein
Cardionerds: A Cardiology Podcast
The CardioNerds podcast episode delves into the use of anti-arrhythmic drugs for managing atrial fibrillation and atrial flutter, featuring a discussion with Dr. Andrew Epstein. The panel addresses the role of both medication and ablation in treating AFib, emphasizing that they are complementary approaches. They explore the use of Class 1C anti-arrhythmics like flecainide and propafenone, detailing their mechanisms, safety considerations, and appropriate patient selection, including the importance of screening for ischemia. The discussion covers Class 3 drugs like ibutilide, dofetilide, and sotalol, focusing on their efficacy, side effects, and initiation protocols, as well as amiodarone and dronadarone, including their toxicities and monitoring requirements. Additionally, the podcast touches on the use of digoxin for rate control in specific patient populations, such as those with heart failure, and underscores the importance of individualized treatment plans and careful monitoring to ensure patient safety and optimize outcomes.
Part 1: Introduction, Clinical Context
Part 2: Class 1C Agents: Mechanisms, Safety, Screening
Part 3: Class 3 Agents: Potassium Channel Blockers
Part 4: Amiodarone, Dronedarone, Digoxin
Part 5: Summary, Key Takeaways
Sign in to continue reading, translating and more.
Open full episode in Podwise